From: Robust optimization of SVM hyperparameters in the classification of bioactive compounds
Protein | Actives | Inactives |
---|---|---|
5-HT\(_\text {2A}\) | 1836 | 852 |
5-HT\(_\text {2C}\) | 1211 | 927 |
5-HT\(_\text {6}\) | 1491 | 342 |
5-HT\(_\text {7}\) | 705 | 340 |
CDK2 | 741 | 1462 |
M\(_\text {1}\) | 760 | 939 |
ERK2 | 72 | 958 |
AChE | 1147 | 1804 |
A\(_\text {1}\) | 1789 | 2286 |
alpha2AR | 364 | 283 |
beta1AR | 195 | 477 |
beta3AR | 111 | 133 |
CB1 | 1964 | 1714 |
DOR | 2535 | 1992 |
D\(_\text {4}\) | 1034 | 449 |
H\(_\text {1}\) | 636 | 546 |
H\(_\text {3}\) | 2706 | 313 |
HIVi | 102 | 915 |
IR | 147 | 1139 |
ABL | 409 | 582 |
HLE | 820 | 610 |